Migration of renal tumor cells depends on dephosphorylation of Shc by PTEN

International Journal of Oncology

Volumn 38, Issue 3, 2011, Pages 823-831

  Schneider, Elke ^a   Keppler, Romy ^b   Prawitt, Dirk ^a   Steinwender, Christoph ^b   Roos, Frederik C ^a   Thüroff, Joachim W ^a   Lausch, Ekkehart ^b   Brenner, Walburgis ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Metastasis; Migration; PTEN; Renal cell carcinoma; Shc

Indexed keywords

FOCAL ADHESION KINASE; ISOPROTEIN; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE B; PROTEIN SHC;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, RENAL CELL; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; PHOSPHORYLATION; PROGNOSIS; PTEN PHOSPHOHYDROLASE; SHC SIGNALING ADAPTOR PROTEINS; SURVIVAL ANALYSIS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 79952018763     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.893     Document Type: Article

References (45)

1. Leslie NR and Downes CP: PTEN function: how normal cells control it and tumour cells lose it. Biochem J 382: 1-11, 2004. (Pubitemid 39141560)
2. Sulis ML and Parson R: PTEN: from pathology to biology. Trenda Cell Biol 13: 478-483, 2003. (Pubitemid 37289398)
3. Vazquez F, Ramaswamy S, Nakamura N and Sellers WR: Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20: 5010-5018, 2000. (Pubitemid 30431555)
4. Georgescu MM, Dirsch KH, Kaloudis P, Yang H, Pavietich NP and Hannafusa H: Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60: 7033-7038, 2000. (Pubitemid 32059181)
5. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL and Whang YE: Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 97: 4233-4238, 2000. (Pubitemid 30226116)
6. Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV and Bartel PL: Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res 60: 35-37, 2000. (Pubitemid 30058725)
7. Valiente M, Andrés-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE and Pulido R: Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem 280: 28936-28943, 2005. (Pubitemid 41161339)
8. Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N and Sellers WR: Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276: 48627-48630, 2001.
9. Li Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
10. Guldberg P, Thor-Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663, 1997. (Pubitemid 27381203)
11. Bonneau D and Longy M: Mutations of the human PTEN gene. Hum Mutat 16: 109-122, 2000. (Pubitemid 30604900)
12. Beaudet AL and Tsui C: A suggested nomenclature for designating mutations. Hum Mutat 2: 245-248, 1993. (Pubitemid 23231498)
13. Kurose K, Bando K, Fukino K, Sugisaki Y, Araki T and Emi M: Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles. Jpn J Cancer Res 89: 842-848, 1998. (Pubitemid 28432827)
14. Risinger JI, Hayes AK, Berchuck A and Barrett JC: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57: 4736-4738, 1997. (Pubitemid 27468978)
15. Agrawal S, Pilarski R and Eng C: Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN. Hum Mol Genet 14: 2459-2468, 2005. (Pubitemid 41418007)
16. Maehama T and Dixon JE: The tumor suppressor, PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378, 1998. (Pubitemid 28268370)
17. Cully M, You H, Levine AJ and Mak TW: Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184-192, 2006. (Pubitemid 43292562)
18. Leslie NR, Yang X, Downes CP and Weijer CJ: PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr Biol 17: 115-125, 2007.
19. Gu J, Tamura M, Pankov R, Danen EH, Takino T, Matsumoto K and Yamada KM: Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146: 389-403, 1999. (Pubitemid 29369775)
20. Mahimainathan L and Choudhury GG: Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J Biol Chem 279: 15258-15268, 2004. (Pubitemid 38618922)
21. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617, 1998. (Pubitemid 28277707)
22. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S and Hall A: Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303: 1179-1181, 2004. (Pubitemid 38233580)
23. Iliopoulos O, Kibel A, Gray S and Kaelin WG Jr: Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1: 822-826, 1995.
24. Brenner W, Färber G, Herget T, Lehr H-A, Hengstler JG and Thüroff JW: Loss of the tumor suppressor protein PTEN during renal carcinogenesis. Int J Cancer 99: 53-57, 2002. (Pubitemid 34273197)
25. Pear WS, Nolan GP, Scott ML and Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392-8396, 1993. (Pubitemid 23277674)
26. Smith PK, Krohn RI, Hermanson GT, Malia AK, Gartner FH, Provenzano MD, Fujimato EK, Golke NM, Olsen BJ and Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985. (Pubitemid 16258399)
27. Brenner W, Gross S, Steinbach F, Horn S, Hohenfellner R and Thüroff JW: Differential inhibition of renal cancer cell invasion mediated by fibronectin, collagen IV and laminin. Cancer Lett 155: 199-205, 2000. (Pubitemid 30259135)
28. Brenner W, Hempel G, Steinbach F, Hohenfellner R and Thüroff JW: Enhanced expression of ELAM-1 on endothelium of renal cell carcinoma compared to the corresponding normal renal tissue. Cancer Lett 143: 14-21, 1999.
29. Zia MK, Rmali KA, Watkins G, Mansel RE and Jiang WG: The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells. Int J Mol Med 20: 605-611, 2007.
30. Merseburger AS, Hennenlotter J, Kuehs U, Simon P, Kruck S, Koch E, Stenzl A and Kuczyk MA: Activation of PI3K is associated with reduced survival in renal cell carcinoma. Urol Int 80: 372-377, 2008. (Pubitemid 351915024)
31. Pantuck AJ, Seligson DB, Klatte T, Yu H, Leppert JT, Moore L, O'Toole T, Gibbons J, Belldegrun AS and Figlin RA: Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer 109: 2257-2267, 2007. (Pubitemid 46801555)
32. Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S and Figlin RA: Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 173: 1496-1501, 2005. (Pubitemid 40524757)
33. Buentig N, Storkel S and Atzpodien J: Molecular genetic changes in renal cell carcinomas. Urologe A 41: 475-481, 2002. (Pubitemid 36070153)
34. Liliental J, Moon SY, Lesche R, Mamillapalli R, Li D, Zheng Y, Sun H and Wu H: Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol 10: 401-404, 2000. (Pubitemid 30213387)
35. Sanchez T, Thangada S, Wu MT, Kontos CD, Wu D, Wu H and Hla T: PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci USA 102: 4312-4317, 2005. (Pubitemid 40397108)
36. Das S, Dixon JE and Cho W: Membrane-binding and activation mechanism of PTEN. Proc Natl Acad Sci USA 100: 7491-7496, 2003. (Pubitemid 36759997)
37. Mosessian S, Avliyakulov NK, Mulholland DJ, Boontheung P, Loo JA and Wu H: Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex. J Biol Chem 284: 30159-30166, 2009.
38. Odriozola L, Singh G, Hoang T and Chan AM: Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem 282: 23306-23315, 2007. (Pubitemid 47311930)
39. Gu J, Tamura M and Yamada KM: Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143: 1375-1383, 1998. (Pubitemid 28559837)
40. Choma DP, Milano V, Pumiglia KM and Di Persio CM: Integrin alpha3beta1-dependent activation of FAK/Src regulates Rac1-mediated keratinocyte polarization on laminin-5. J Invest Dermatol 127: 31-40, 2007. (Pubitemid 46005658)
41. Yamazaki D, Kurisu S and Takenawa T: Regulation of cancer cell motility through actin reorganization. Cancer Sci 96: 379-386, 2005. (Pubitemid 41179738)
42. Sarbassov DD, Guertin DA, Ali SM and Sabatini DM: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101, 2005. (Pubitemid 40262113)
43. Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K and Takahashi M: Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 9: 389-402, 2005. (Pubitemid 41235808)
44. Li J, Ballif BA, Powelka AM, Dai J, Gygi SP and Hsu VW: Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration. Dev Cell 9: 663-673, 2005. (Pubitemid 41555148)
45. Yamada KM and Araki M: Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 114: 2375-2382, 2001. (Pubitemid 32684793)